Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

A 29-year-old female patient is evaluated in the outpatient clinic for secondary amenorrhea, having not experienced a menstrual period for the past seven months. Her prior cycles were regular. She also reports a spontaneous, bilateral milky nipple discharge and intermittent frontal headaches over the past few weeks. She denies visual changes, temperature intolerance, or recent weight fluctuations. Vital signs include a blood pressure of 118/76 mm Hg, heart rate of 72/min, and respiratory rate of 14/min. Her body mass index is 23 kg/m². Visual field testing by confrontation reveals no deficits. Arrange the following clinical steps in the most appropriate chronological sequence for the evaluation and management of this patient's condition.

  1. 1Perform a qualitative urine beta-hCG test
  2. 2Measure serum prolactin and thyroid-stimulating hormone (TSH) levels
  3. 3Obtain dedicated neuroimaging of the sella turcica
  4. 4Initiate treatment with a dopamine agonist

Cevap

The correct sequence of evaluation and management is: 1) Perform a qualitative urine beta-hCG test, 2) Measure serum prolactin and TSH levels, 3) Obtain dedicated neuroimaging of the sella turcica, and 4) Initiate treatment with a dopamine agonist.
The patient presents with classic signs of a prolactin-secreting pituitary adenoma: secondary amenorrhea, galactorrhea, and headaches. According to best-practice guidelines for secondary amenorrhea and galactorrhea, the evaluation must be performed in a step-wise manner. The absolute first step in any reproductive-aged woman with amenorrhea is to rule out pregnancy with a beta-hCG test. Once pregnancy is excluded, serum prolactin and TSH levels must be evaluated. TSH is necessary because primary hypothyroidism causes elevated TRH, which directly stimulates prolactin secretion. If prolactin is significantly elevated and TSH is normal, a central structural cause (prolactinoma) is suspected, prompting dedicated neuroimaging (MRI) of the pituitary gland. Finally, once a prolactinoma is confirmed anatomically and biochemically, medical treatment with a dopamine agonist (such as cabergoline) is initiated to reduce tumor size and normalize endocrine function.

Adım Adım Çözüm

1
Rule out pregnancy
Perform a qualitative urine beta-hCG test
Pregnancy is the most common cause of secondary amenorrhea and can also naturally cause galactorrhea. It must be excluded before any further workup.
2
Evaluate for biochemical endocrine abnormalities
Measure serum prolactin and thyroid-stimulating hormone (TSH) levels
Hyperprolactinemia inhibits GnRH release, causing amenorrhea. Primary hypothyroidism can cause hyperprolactinemia due to TRH acting as a prolactin secretagogue, so TSH must be checked simultaneously.
3
Localize the structural pathology
Obtain dedicated neuroimaging of the sella turcica
Once hyperprolactinemia is biochemically confirmed (and hypothyroidism ruled out), an MRI is required to evaluate for a pituitary adenoma, particularly given the patient's new-onset headaches.
4
Treat the underlying etiology
Initiate treatment with a dopamine agonist
Cabergoline or bromocriptine is the first-line medical therapy for prolactinomas to normalize prolactin levels, restore menses, and shrink the tumor size.

Anahtar Kavram

The evaluation of secondary amenorrhea with galactorrhea follows a strict stepwise algorithm: excluding pregnancy, confirming biochemical hyperprolactinemia/hypothyroidism, obtaining anatomical neuroimaging, and then initiating medical management.
Tahmini Süre:1m 30s
Bu soruyu puanla